Back to discover

Protein / target

Breast cancer type 2 susceptibility protein

Encoded byBRCA2P51587Homo sapiensSwiss-Prot
Small-molecule tractable
Druggability
Structure with Ligand
12
Research papers

Protein at a glance

Biological role

Histone H3 acetyltransferase

Strongest disease association

Ovarian Neoplasms

Via encoding gene BRCA2 · Genetic evidence · score 0.95

Research activity

Emerging research

12 papers · latest 2025

Derived from structured UniProt, Open Targets and literature data on this page.

Protein profile

UniProt 2026_02

Canonical identity and biological annotation from UniProt.

Function overview

Tumor suppressor protein that maintains genome stability primarily by repairing damaged DNA through homologous recombination (HR).

View complete UniProt function annotation

Tumor suppressor protein that maintains genome stability primarily by repairing damaged DNA through homologous recombination (HR) (PubMed:11239456, PubMed:12442171, PubMed:15115758, PubMed:15199141, PubMed:15671039, PubMed:15937124, PubMed:17515903, PubMed:17515904, PubMed:18317453, PubMed:19303847, PubMed:20729832, PubMed:20729858, PubMed:20729859, PubMed:21719596, PubMed:27941124, PubMed:37499663, PubMed:37515771). Facilitates the repair of double-strand breaks (DSBs) by binding and mediating the loading of the RAD51 protein onto single-stranded DNA (ssDNA), thereby promoting the activity of RAD51, which catalyzes DNA strand exchange (PubMed:11239456, PubMed:12442171, PubMed:15937124, PubMed:17515903, PubMed:17515904, PubMed:18317453, PubMed:19303847, PubMed:20729832, PubMed:20729858, PubMed:20729859, PubMed:27941124, PubMed:37499663). BRCA2 nucleates and stabilizes RAD51 on ssDNA directly and delivers RAD51 to ssDNA-double-stranded DNA (dsDNA) junctions by sliding along dsDNA backbone (PubMed:12442171, PubMed:19303847, PubMed:37499663). RAD51 targeting to ssDNA promotes removal of replication protein-A (RPA) from ssDNA and stabilization of RAD51-ssDNA filaments by blocking ATP hydrolysis (PubMed:20729859). May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks; together with PALB2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity (PubMed:24485656). Required to prevent R-loop-associated DNA damage and thus transcription-associated genomic instability (PubMed:24896180). Silencing of BRCA2 promotes R-loop accumulation at actively transcribed genes in replicating and non-replicating cells, suggesting that BRCA2 mediates the control of R-loop associated genomic instability, independently of its known role in homologous recombination (PubMed:24896180). Also promotes RAD51 loading to telomeric regions, facilitating telomere replication and capping (PubMed:21076401). Also required for homologous recombination during meiosis by promoting the recruitment of RAD51 and DMC1 recombinases to meiotic DSB sites, enabling proper chromosome pairing and crossing over (PubMed:26976601). Also promotes homologous recombination by inactivating the FIGNL1-FIRRM complex to protect RAD51 filament from premature disassembly (PubMed:37515771). Together with NPM1, may also regulate centrosome duplication (PubMed:21084279)

Subcellular location

ChromosomeChromosome, telomereNucleusCytoplasm, cytoskeleton, microtubule organizing center, centrosome
Domains and Gene Ontology detail (28)

Gene Ontology

  • CBRCA2-MAGE-D1 complex
  • Ccentrosome
  • Cchromosome, telomeric region
  • Ccytosol
  • Clateral element
  • Cnucleoplasm
  • Cnucleus
  • Cprotein-containing complex
  • Csecretory granule
  • Fgamma-tubulin binding
  • Fhistone H3 acetyltransferase activity
  • Fhistone H4 acetyltransferase activity

3418 aa · 384 kDa

Biological roles

What this protein does, drawn together from its UniProt function, Gene Ontology terms and Reactome pathways.

Tumour suppressionUniProtTranscriptional regulationUniProt · GOMetabolic enzyme activityGO
View supporting evidence

Tumour suppression

  • ·Tumor suppressor protein that maintains genome stability primarily by repairing damaged…

Transcriptional regulation

  • ·Tumor suppressor protein that maintains genome stability primarily by repairing damaged…
  • ·positive regulation of DNA-templated transcription
  • ·regulation of DNA-templated transcription

Metabolic enzyme activity

  • ·histone H3 acetyltransferase activity
  • ·histone H4 acetyltransferase activity

Concepts derived from UniProt GO Reactome — each badge above shows which sources supported that role.

Translational evidence

Open Targets 26

Why this target matters therapeutically, strongest evidence first. Disease associations are gene-level (via the gene that encodes this protein) and open into the full confidence synthesis; the development universe, tractability and safety annotations are target-level, from Open Targets.

Strongest disease associations · via encoding gene BRCA2

Gene-level evidence surfaced through the gene BRCA2 that encodes this protein — not a direct protein–disease relationship. Ranked by Forefront's causal-directness weighting, so genetically- and clinically-evidenced diseases lead over ones that merely share the literature.

Ovarian Neoplasms
0.98Well supported

Genetic evidence dominant · Open Targets 0.78

Neoplasms
0.96Well supported

Genetic evidence dominant · Open Targets 0.81

Breast Neoplasms
0.96Well supported

Genetic evidence dominant · Open Targets 0.81

View evidence synthesis (3)
Ovarian NeoplasmsWell supported
0.98
agreement 0.871.00
Genetic57%Somatic mutation34%Literature9%

Open Targets aggregate 0.78 · 3 independent evidence families

NeoplasmsWell supported
0.96
agreement 0.841.00
Genetic64%Pathway26%Literature10%Genetic literaturedup

Open Targets aggregate 0.81 · 3 independent evidence families · 1 not counted as duplicate

Breast NeoplasmsWell supported
0.96
agreement 0.851.00
Genetic58%Somatic mutation36%Literature6%

Open Targets aggregate 0.81 · 3 independent evidence families

This ranking differs from Open Targets' own: re-weighting moves genetically-evidenced diseases above more heavily co-mentioned ones. The evidence agreement range shows how closely the independent evidence families agree — it is not a statistical confidence interval, and nothing here is fitted to outcome data. Derived from Open Targets evidence types under Forefront weighting; the per-type scores above show the calculation.

Show all associations
Neoplasms0.81
Breast Neoplasms0.81
Ovarian Neoplasms0.78

Tractability

Small moleculesEmerging

Feasibility evidence (structure with ligand) — no clinical-stage drug of this modality recorded.

Protein degradersEmerging

Feasibility evidence (uniprot ubiquitination and database ubiquitination) — no clinical-stage drug of this modality recorded.

View underlying tractability evidence (3)
SM · Structure with LigandPR · UniProt UbiquitinationPR · Database Ubiquitination

Raw Open Targets tractability assessment buckets, by modality.

Research activity

12 papers · to 2025

Papers linked directly to this protein. This is the protein's own literature — descriptor-derived papers are kept separate below.

Most cited

Colaprico A · Nucleic acids research · 2016

Kaufman B · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2015

Abida W · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020

Won KA · International journal of oncology · 2020

Recent

Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a <i>BRCA1</i> or <i>BRCA2</i> Gene Alteration.

Abida W · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020

Europe PMC papers linked directly to this protein.